<DOC>
	<DOCNO>NCT01013337</DOCNO>
	<brief_summary>RATIONALE : Acupuncture may help relieve moderate severe joint pain cause aromatase inhibitor . PURPOSE : This randomized phase II trial study acupuncture treat woman stage I , stage II , stage III breast cancer aromatase inhibitor-related joint pain .</brief_summary>
	<brief_title>Acupuncture Treating Women With Stage I , Stage II , Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine overall effect acupuncture reduce arthralgia among breast cancer survivor ( BCS ) receive AIs . II . To explore specific effect acupuncture needle reduce arthralgia among BCS receive AIs . III . To elucidate relationship response expectancy measure Acupuncture Expectancy Scale ( AES ) clinical response acupuncture define percent reduction BPI pain severity score end intervention . SECONDARY OBJECTIVES : I . To explore effect acupuncture common symptom include fatigue , insomnia , psychological distress among BCS experience joint pain . II . To determine correlation among pain fatigue , insomnia , psychological distress use previously validate instrument . III . To explore effect acupuncture quality life among BCS experience joint pain . IV . To explore effect acupuncture objective measure sleep activity . V. To identify potential genetic determinant response acupuncture . OUTLINE : Patients randomize 1 3 treatment arm . ARM I ( Acupuncture ) : Patients undergo 10 , 20-minute session acupuncture 8 week ( twice weekly 2 week 6 weekly treatment ) . ARM II ( Placebo ) : Patients undergo 10 , 20-minute session sham acupuncture treatment 8 week ( twice weekly 2 week 6 weekly treatment ) via Streitberger needle non-acupuncture point . ARM III ( Control ) : Wait-list control patient contact phone frequency real placebo acupuncture group data collection week 1 , 4 , 8 . After completion study treatment , patient follow 4 week .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Inclusion History stage I , II , III breast cancer Visit oncologist within previous 3month period free disease clinical examination history Currently receive aromatase inhibitor ( Anastrozole , Letrozole , Exemestane ) per chart abstraction Postmenopausal , define cessation menses least 1 year FSH &gt; 40 mlU/mL Can understand write English Having bad joint pain rat least 4 great 11point ( 010 ) numerical rating scale precede week Having least 15 day pain precede 30 day Having joint pain least 3 month Joint pain attribute use aromatase inhibitor Willingness adhere studyrelated procedure include randomization one three possible choice : real acupuncture , placebo acupuncture , waitlist control Exclusion Women metastatic ( stage IV ) breast cancer Women finish chemotherapy radiation therapy le 4 week prior enrollment History bleed disorder Joint pain attribute inflammatory arthritis ( rheumatoid arthritis , gout , pseudo gout ) Having severe pain noninflammatory arthralgia prior AI initiation per patient 's history Surgery joint injection involve treatment joint within last 3 month Have previously participate acupuncture trial hot flash last year</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>